CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
This is the first update to the original CTS communication distributed on July 6th. As previously co...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
We have now added a new section called the "Assay History List" to the "At A Gla...